Rabbit Oral Papillomavirus Complete Genome Sequence and Immunity Following Genital Infection  by Christensen, Neil D. et al.
dVirology 269, 451–461 (2000)
doi:10.1006/viro.2000.0237, available online at http://www.idealibrary.com onRabbit Oral Papillomavirus Complete Genome Sequence
and Immunity Following Genital Infection
Neil D. Christensen,*,†,1 Nancy M. Cladel,* Cynthia A. Reed,* and Ricai Han*
*Department of Pathology, The Jake Gittlen Cancer Research Institute, and †Department of Microbiology and Immunology,
The Milton S. Hershey Medical Center, Penn State College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033
Received December 23, 1999; returned to author for revision January 14, 2000; accepted February 2, 2000
Rabbit oral papillomavirus (ROPV) infects mucosal tissues of domestic rabbits. The viral genomic sequence has been
determined and the most related papillomavirus type was the cutaneous cottontail rabbit papillomavirus (CRPV). Homologies
between the open reading frames (ORFs) of ROPV and CRPV, however, ranged from 68% amino acid identity for L1 to only
23% identity for E4. Shared features unique to the two rabbit viruses included a large E6 ORF and a small E8 ORF that
overlapped the E6 ORF. Serological responses to ROPV L1 viruslike particles (VLPs) were detected in rabbits infected at
either the genital or oral mucosa with ROPV. The antibody response was specific to intact ROPV L1 VLP antigen, was first
detected at the time of late regression, and persisted at high levels for several months after complete regression. Both oral
and genital lesions regressed spontaneously, accompanied by a heavy infiltrate of lymphocytes. ROPV infection of rabbit
genital mucosa is a useful model to study host immunological responses to genital papillomavirus infections. © 2000 Academic
PressINTRODUCTION
Rabbit oral papillomavirus (ROPV) is a natural infection
of domestic rabbits (Parsons and Kidd, 1936, 1942; Rich-
ter et al., 1964; Mews et al., 1972; Sundberg et al., 1985;
O’Banion et al., 1988). The virus causes benign epithelial
infections in the oral cavity that are usually confined to
the undersurface of the tongue. These lesions quickly
regress at about 50 days after experimental infection of
almost all animals. Although first described in 1936 (Par-
sons and Kidd, 1936), ROPV has been the focus of only a
limited number of studies, confined mostly to ultrastruc-
tural analyses (Richter et al., 1964; Rdzok et al., 1966;
Sundberg et al., 1985) and incidence of natural infection
(Parsons and Kidd, 1936, 1942; Mews et al., 1972;
Dominguez et al., 1981; O’Banion et al., 1988). Our labo-
ratory has recently begun studies with ROPV as a model
system to examine tissue susceptibility and immunity to
a mucosal-targeting papillomavirus. We have used the
athymic mouse xenograft system (Kreider et al., 1985) to
develop stocks of ROPV (Christensen et al., 1996) and
have determined that direct infection of adult male gen-
ital tissues can result in ROPV-induced lesions, which
contain ROPV DNA and viral capsid antigen (Harvey et
al., 1998).
The purpose of this study is to report the entire DNA
sequence of the ROPV genome and to describe the time
course and specificity of a serological immune response1 To whom correspondence and reprint requests should be ad-
ressed. Fax: (717) 531-5634. E-mail: ndc1@email.psu.edu.
451to capsid antigen in rabbits infected at genital sites with
infectious ROPV. DNA sequence comparisons between
ROPV and other papillomaviruses revealed that the most
closely related was cottontail rabbit papillomavirus
(CRPV). We observed a strong serological response to
ROPV L1 viruslike-particle (VLP) antigens in rabbits in-
fected at either oral or genital sites, which reached
maximum levels after regression of the lesions. These
serological responses to ROPV L1 VLP antigens were a
clear additional indicator for active genital papillomavi-
rus infections.
RESULTS
ROPV genome
The complete genome of ROPV was determined to
contain 7565 bp (Fig. 1). The numbering and identifica-
tion of nucleotide position 1 was determined by consen-
sus alignment with other papillomavirus genomes at the
region of the palindromic E1 binding region within the
upstream regulatory region (URR). Open reading frames
(ORFs) were located on one DNA strand and identified by
position and homology to represent typical papillomavi-
rus genes (Fig. 2). Amino acid (aa) sequence homology
comparisons were determined for selected animal and
human papillomaviruses and the greatest homology was
observed between ROPV and CRPV genes with the ex-
ception of E7, which showed a similar level of highest
homology with both COPV and HPV-11 E7 (Table 1).
Next-highest levels of homology were found for HPV-1a
ORFs, which correlated with the relatedness of the CRPV
0042-6822/00 $35.00
Copyright © 2000 by Academic Press
All rights of reproduction in any form reserved.
986 T.
452 CHRISTENSEN ET AL.and HPV1a viral sequences in phylogeny studies (Myers
et al., 1996). A small URR of 478 bp (bases 7185–98) was
present which is considerably smaller than the CRPV
URR of 675 bp. The ROPV URR contained four consensus
E2 binding motifs (compared to 10 for the CRPV URR),
beginning at positions 7272, 7466, 7519, and 39, in com-
mon with most HPV URRs. Polyadenylation consensus
sequences (AATAAA) were found in the 59 end of the URR
(at bp 7218) and within the beginning of the L2 gene (bp
positions 4320 and 4332), representing typical polyade-
nylation sites of the late and early viral transcripts, re-
spectively. Additional consensus polyadenylation se-
quences were also present between the E6 and E7 ORFs
FIG. 1. ROPV genome: 7565 bp. Composition: 2221 A; 1550 C; 1808 G; 1(bp 843), within the E1 ORF (bp 2811), and within the L1
ORF (bp 5919). Viral RNA transcript analysis was notconducted to determine whether these latter putative
polyadenylation signals are functional.
Immunological responses to ROPV infection at oral or
genital sites
Serological responses to ROPV L1 VLP antigens were
determined for rabbits infected with ROPV at oral and
penile mucosal sites. Antibody titers were calculated for
each serum bleed, and the data plotted against time from
initial infection for individual rabbits (Figs. 3 and 4). High
titers of anti-ROPV L1 VLP-reactive antibodies developed
in rabbits infected on the undersurface of the tongue
Coding strand (only) shown. GenBank Accession number: AF227240.(Fig. 3A). The antibodies persisted at high levels for more
than 100 days after complete regression of the papillo-
—Conti
453ROPV GENOMEmas. Cyclosporine A (CsA) treatment of rabbits with
tongue lesions induced a delay in the serological re-
sponse, and prevented spontaneous regressions of the
papillomas for the duration of the CsA treatment (Fig. 3B).
Rabbits infected at penile sites also developed strong
serological responses to ROPV L1 VLPs that persisted
long after regression of the penile lesions (Fig. 4A). CsA
FIG. 1treatment again prevented regression of the papillomas
and, in this instance, prevented the appearance of serumantibodies to ROPV L1 VLPs for the duration of CsA
treatment (Fig. 4B).
Further serological responses to ROPV infection of
male penile and female vaginal surfaces were con-
ducted. Serum antibody responses to ROPV L1 VLPs
were first detected 50 days after infection of male genital
tissues following abrasion with fine sandpaper (Table 2).
nuedRaised penile lesions similar to those found after ROPV
infection of needle puncture sites were obtained. No
—Conti
454 CHRISTENSEN ET AL.macroscopic papillomas were observed at vaginal sites
that were exposed to the ROPV inoculum (the entire
genital tract was not examined, however), and no sero-
logical responses to ROPV L1 VLP antigens of these
latter rabbits were found (Table 2).
Specificity of immune responses to ROPV L1 VLP
antigens
FIG. 1The specificity of immunity to ROPV L1 proteins was
tested in ELISA with the use of sera from rabbits infected atpenile and oral sites with ROPV and from rabbits infected at
cutaneous sites with CRPV. Monoclonal antibodies pre-
pared against the L1 VLPs of ROPV (see below) and CRPV
(Christensen and Kreider, 1991) were used as specificity
controls. Sera from rabbits infected with ROPV at either
penile or oral mucosal sites generated antibody responses
predominantly to intact ROPV L1 VLPs (Table 3). A response
to denatured ROPV L1 antigen was detected in the sera of
nuedone rabbit infected at penile sites, and only at the time point
of 100 days after complete regression of the lesions. Some
FIG. 1—Continued
455ROPV GENOMEFIG. 2. Open reading frames of ROPV. Positions of start and stop codons are displayed for the plus strand only. Nucleotide numbering system and
ORFs are identified by consensus comparison with other papillomavirus genomes.
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456 CHRISTENSEN ET AL.background responses of this rabbit sera to intact CRPV L1
VLP antigen preparations were observed that may be
anomalous, because the preimmune sera was equally re-
active. Mouse monoclonal antibodies (Mabs) prepared
against ROPV L1 VLPs showed strong and specific reac-
tivity only to the intact VLP antigen (Table 3), in common
with many of the papillomavirus VLP-reactive Mabs that we
T
Amino Acid Sequence Identity between ROPV OR
Virus E6 E8 E7 E1
CRPV 29.9 40.0 36.5 61.5
COPV 15.9 — 38.4 46.7
PV-1 12.2 16.3 22.8 40.9
PV-4 — 17.7 34.0 41.9
PV-11 15.2 — 36.7 42.1
PV-16 15.1 — 30.0 43.1
PV-18 16.0 — 35.2 42.1
PV-1a 21.0 18.6 33.3 50.1
a Predicted protein sizes for ROPV E1 (616 aa), E2 (414 aa), E4 (212 a
FIG. 3. Serological response to ROPV L1 VLP antigen in sera from
abbits infected at oral tongue sites. Six infected rabbits were sepa-
ated into two groups, one of which received chronic CsA treatment for
0 days. Papillomas were inspected visually over the period of the
xperiment.and others have developed (Cowsert et al., 1987; Chris-
tensen et al., 1990; Christensen and Kreider, 1991; Roden et
al., 1994; Christensen et al., 1996; Kulski et al., 1998).
Competition ELISAs for ROPV L1 VLP reactive mouse
Mabs and rabbit antibodies
Two competition ELISAs were set up to determine
whether ROPV L1 VLP reactivity in the sera of infected
d Selected Animal and Human Papillomaviruses
reading framea
E2 E4 E5 L2 L1
55.1 22.9 27.7 48.8 68.4
39.3 18.1 11.0 39.4 57.1
34.7 16.0 9.6 25.8 46.7
39.9 20.0 9.6 34.5 51.9
35.2 17.7 14.3 32.3 52.8
33.0 14.6 14.8 34.3 48.6
30.7 12.4 12.5 35.5 57.3
46.1 19.1 9.6 43.1 57.3
3 aa), E6 (237 aa), E7 (93 aa), E8 (50 aa), L1 (499 aa), and L2 (482 aa).
FIG. 4. Serological response to ROPV L1 VLP antigens in the sera ofABLE 1
Fs an
Openrabbits infected at penile mucosal sites. Assays and procedures are as
described in Fig. 3.
couring
nsion.
457ROPV GENOMErabbits competed with type-specific ROPV L1 VLP-reac-
tive mouse Mabs. A set of five Mabs were shown to
block subsequent rabbit antibody binding to varying de-
grees, with almost complete blocking obtained with Mab
ROPV-5A and limited blocking by Mab ROPV-3B (Fig. 5).
Blocking ranged from 25 to 98%, and was equivalent for
all four rabbit sera tested (two sera from rabbits with
tongue lesions and the remaining two from rabbits with
penile infections). The differences in blocking potential
between the mouse Mabs were not the result of different
concentrations of antibody in the tissue culture superna-
tants, as these Mabs showed similar titers in ROPV L1
VLP ELISAs (data not shown).
In a reciprocal competition ELISA, rabbit serum from
ROPV-infected rabbits blocked the binding of one of the
mouse Mabs (ROPV-2A) chosen at random. Blocking was
almost complete at low dilutions of rabbit sera (Fig. 6),
and the level of blocking correlated with the titer of
VLP-specific antibodies present in the rabbit sera (Figs. 3
and 4). Sera from rabbits infected at either oral or penile
sites were effective at blocking the subsequent binding
of Mab ROPV-2A to intact VLP antigen.
DISCUSSION
T
Time Course of Serum Antibody Reactivity to R
Days after infection with ROPV R
H0790 (male
0 0.002 (0.002
18 0.003 (0.001
34 0.013 (0.002
53 0.273 (0.012
89 1.116 (0.059
H0789 (female
0 0.001 (0.002
30 0.001 (0.001
46 0.003 (0.003
65 0.003 (0.000
101 0.012 (0.002
H0353 (female
0 0.010 (0.001
21 0.012 (0.001
34 0.002 (0.002
69 0.004 (0.005
a Means 6 SEM of optical density (OD) readings for duplicate wells
b Male rabbits infected at penile sites following light abrasion with
c Female rabbits infected at vaginal opening with ROPV after light s
d Female rabbits given intravaginal infusion of 10 ml of ROPV suspeModel systems to assess host immunological re-
sponses to genital papillomavirus infections are cur-rently inadequate. The absence of small animal models
of genital papillomavirus infection together with the tis-
sue- and species-restricted nature of papillomaviruses
has contributed to these deficiencies. We have begun
preliminary characterization of a rabbit model of genital
papillomavirus infection using ROPV. Our initial studies
focused on the establishment of genital papillomavirus
infections and the examination of tissue susceptibility
(Christensen et al., 1996; Harvey et al., 1998). In the
current study, we present the complete ROPV genomic
sequence and a serological analysis to capsid antigens
of rabbits infected at either the oral or the genital mu-
cosa.
The ROPV genome is organized similarly to all previ-
ously published papillomavirus genomes. The most
closely related papillomavirus to ROPV is CRPV, although
the homology that was greatest for the L1 ORF was only
68% aa identity. Unique features shared between ROPV
and CRPV include: (1) an extended E6 ORF with highly
conserved sequences in the region of an internal or
second methionine (Barbosa and Wettstein, 1987); (2) a
small E8 ORF, overlapping the E6 ORF, which has fea-
tures similar to BPV-1 and HPV E5 ORFs; (3) a small
noncoding region between the E6 and E7 ORFs; and (4)
VLP in Adult Rabbits Infected at Genital Sites
umber and ELISA (mean 6 SEM) of OD valuesa
H0791 (male)b
0.001 (0.001)
0.001 (0.001)
0.006 (0.002)
0.137 (0.005)
1.096 (0.009)
H0792 (female)c
20.002 (0.002)
20.001 (0.001)
0.001 (0.001)
0.001 (0.002)
0.000 (0.000)
H0369 (female)d H0374 (female)d
0.012 (0.002) 0.004 (0.001)
0.028 (0.011) 0.007 (0.004)
0.025 (0.003) 0.013 (0.003)
0.013 (0.005) 0.034 (0.001)
rlined values are considered positive for reactivity.
per.
with a plastic pipette tip.ABLE 2
OPV L1
abbit n
)b
)
)
)
)
)
)c
)
)
)
)
)
)d
)
)
)
)
; unde
sandpaan E5 ORF located within the traditional site of other
papillomavirus E5 ORFs, but not containing features typ-
ider, 1991) and CRPV L1 VLP antigen.
458 CHRISTENSEN ET AL.ical of E5 ORFs. Homology between ROPV E8 and CRPV
E8 was high at 40% aa identity, but was low for compar-
isons between ROPV E8 and BPV-4 E8 (18%) and BPV-1
E5 (16%). The URR of ROPV is relatively short, consisting
of 478 bp. Four E2-binding sites are located in the URR
and three of these are optimal consensus binding se-
quences (Li et al., 1989; McBride et al., 1991). These
features of the ROPV URR contrast with those of the
CRPV URR, which is 678 bp and contains 10 E2-binding
sites (Giri et al., 1985). The regions of the genome of a
different ROPV isolate that were previously published
(portions of E2, E4, and L2) were almost identical to the
isolate sequenced in this study (O’Banion et al., 1988).
Several interesting observations regarding the ROPV
genome were noted. A consensus polyadenylation se-
quence is located between the E6 and E7 ORFs, a
feature not observed in any other papillomavirus se-
quence (Bernard et al., 1994). We have not examined viral
T
Specificity of Serum Antibody from ROPV-Infected Rabbits, and
Serum (1:50) or Mab (1:20)
ROPV L1 VLP
Intacta
dG0847 preimmuneb 0.000 (0.000)
G0847 (day 58) 0.338 (0.060)
G0847 (day 168) 0.263 (0.031)
G0848 preimmuneb 0.000 (0.000)
G0848 (day 58) 0.437 (0.052)
G0858 (day 168) 0.444 (0.001)
G0851 preimmunec 0.000 (0.000)
G0851 (day 58) 0.278 (0.014)
G0851 (day 168) 0.253 (0.007)
G0852 preimmunec 0.000 (0.001)
G0852 (day 58) 0.258 (0.052)
G0852 (day 168) 0.377 (0.008)
CRPV progressord 0.020 (0.005)
CRPV regressord 0.001 (0.002)
CRPV cancer bearerd 0.021 (0.003)
ROPV-1De 0.824 (0.060)
ROPV-2Ae 1.424 (0.252)
ROPV-3Be 0.371 (0.021)
ROPV-4De 0.301 (0.065)
ROPV-5Ae 0.508 (0.073)
CRPV-4B f 0.000 (0.000)
CRPV-10B f 0.000 (0.000)
(2) 0.000 (0.000)
a Means 6 SEM of OD readings of duplicate wells; underlined valu
b Rabbits infected with ROPV at oral sites; day numbers are days af
c Rabbits infected with ROPV at penile sites; day numbers are days
d CRPV-infected rabbits representing a progressor, regressor and ca
e Mouse Mabs generated against ROPV L1 VLP antigen.
f Mouse Mabs generated against CRPV virion (Christensen and KreABLE 3
Mouse Monoclonal Antibodies to ROPV and CRPV L1 VLP Antigens
antigen CRPV L1 VLP antigen
Disrupted Intact Disrupted
0.004 (0.002) 0.004 (0.002) 0.009 (0.000)
0.003 (0.001) 0.009 (0.003) 0.013 (0.001)
0.002 (0.002) 0.005 (0.001) 0.012 (0.000)
0.002 (0.001) 0.003 (0.002) 0.008 (0.001)
0.005 (0.001) 0.003 (0.002) 0.009 (0.000)
0.005 (0.002) 0.007 (0.003) 0.008 (0.000)
0.003 (0.002) 0.000 (0.000) 0.027 (0.001)
0.009 (0.003) 0.000 (0.000) 0.016 (0.001)
0.010 (0.000) 0.006 (0.000) 0.019 (0.001)
0.021 (0.004) 0.086 (0.002) 0.029 (0.001)
0.008 (0.004) 0.084 (0.006) 0.016 (0.001)
0.200 (0.010) 0.107 (0.005) 0.279 (0.013)
0.025 (0.003) 0.127 (0.015) 0.520 (0.040)
0.009 (0.002) 0.328 (0.061) 0.009 (0.001)
0.023 (0.003) 0.394 (0.006) 0.250 (0.020)
0.002 (0.000) 0.001 (0.002) 0.005 (0.000)
0.013 (0.010) 0.000 (0.001) 0.004 (0.000)
0.000 (0.001) 0.001 (0.002) 0.004 (0.000)
0.007 (0.006) 0.001 (0.002) 0.004 (0.001)
0.001 (0.001) 0.002 (0.002) 0.003 (0.000)
0.000 (0.000) 1.711 (0.013) 0.002 (0.000)
0.000 (0.000) 0.322 (0.006) 1.101 (0.063)
0.000 (0.000) 0.000 (0.000) 0.000 (0.000)
es are considered positive.
ter ROPV infections.
after ROPV infections.
ncer-bearer.mRNA species to determine whether this site is active
within the ROPV lesions. This putative polyadenylationFIG. 5. Competition ELISA. Five ROPV L1 VLP-specific monoclonal
antibodies (ROPV-1D to ROPV-5A) were tested for blocking of the
binding to ROPV L1 VLPs of antibodies in the sera of rabbits infected
with ROPV at oral (G0847, G0848) or penile (G0851, G0852) mucosal
sites.
459ROPV GENOMEsequence was present in a second ROPV clone and thus
does not appear to be a sequencing artifact. Three ROPV
genomes were independently isolated and all three con-
tained apparent mutations within the E1 ORF. Two ge-
nomes contained mutations represented by single-base
deletions at aa positions 520 and 560, respectively, that
would result in truncated E1 ORFs. Each mutation was
present in only one of three ROPV genomes sequenced
at this region, and we have altered the final ROPV se-
quence (Fig. 1) to reflect a full-length E1 ORF coding for
a 616-aa protein. The third genome contained a 777-bp
insertion within the E1 ORF at aa position 564. This insert
sequence represented a 9-bp duplication of the E1 se-
quence TAAAAAGTG at the insertion site together with a
768-bp sequence identical to the IS1 sequence or trans-
poson of E. coli (Ohtsubo and Ohtsubo, 1978). We predict
that all three ROPV genomes would be dysfunctional
because of these mutations.
Immunological responses to genital infection with
ROPV were detectable by several assays. Indirect ev-
idence for cell-mediated immunity was observed as a
spontaneous regression of lesions accompanied by
an intense infiltrate of lymphocytes (data not shown).
Further evidence for cell-mediated immunity to genital
ROPV infection was demonstrated by a delay in re-
gression following chronic CsA treatment. We also
detected serological responses to ROPV L1 VLP anti-
gen by ELISA in rabbits infected at either oral or male
genital mucosal sites. A strong, long-lasting, specific-
antibody response occurred following mucosal infec-
tion, and this antibody reactivity was an effective indi-
cator for the presence of active disease. Antibody
titers were approximately 1 log higher for rabbits in-
FIG. 6. Competition ELISA. Sera from rabbits infected with ROPV at
oral (G0847, G0848) or penile (G0851, G0852) mucosal sites were tested
for blocking of the binding to ROPV L1 VLP by the mouse Mab,
ROPV-2A.fected at oral versus penile sites, and this is probably
because there were more lesions at the oral surface.In some rabbits, the penile lesions were very small
and not easily detectable by visual inspection. In con-
trast, oral lesions were easily observed. No papillo-
mas were noticed in female rabbits inoculated intra-
vaginally with ROPV and no serum-antibody responses
were found in these rabbits. These observations sug-
gest that the methods used to infect vaginal tissues
with ROPV were unsuccessful. The vaginal tissues
were soft, and we did not puncture the mucosa as was
done for the oral and penile sites of infection. Previous
studies using the athymic mouse xenograft system
have demonstrated that female rabbit vaginal tissue is
susceptible to ROPV infection, and these xenografts
contained infectious ROPV virions (Christensen et al.,
1996; Harvey et al., 1998). Thus, the lack of serological
responses in the female rabbits used in this study
suggests that active disease was absent, and would
necessitate wounding of vaginal tissues in a manner
similar to the wounding of male penile and oral mu-
cosal tissues.
Chronic treatment with CsA prevented spontaneous
regression of both oral and penile lesions. The papillo-
mas in these rabbits were larger in size than in non-CsA-
treated rabbits, and the penile lesions were capsid-anti-
gen positive (Harvey et al., 1998). CsA-treated rabbits
with penile lesions may provide a small animal model for
studying natural genital transmission of papillomavirus
infections.
Competition ELISAs between ROPV L1 VLP-specific
mouse Mabs and sera from rabbits infected with ROPV
showed high levels of cross-blocking. One mouse Mab
in particular (ROPV-5A) was able to block completely the
binding of specific rabbit serum antibodies from rabbits
with either oral or genital infections. These observations
indicate that immunodominant, conformationally depen-
dent VLP epitopes are the major ROPV capsid sites
recognized by host antibodies during infection and im-
munization. Similar observations have been obtained for
HPV-16 VLP-specific Mab H16.V5 and patient sera (Wang
et al., 1997), and sera from calves infected with BPV-1
and mouse Mab B1.A1 (Christensen and Kreider, 1993).
We have seen similar interference responses between
sera from rabbits infected with CRPV and CRPV-VLP-
specific mouse Mabs (unpublished data). The immu-
nodominance of conformational epitopes thus appears
to be a common feature of antibody responses to capsid
antigens during papillomavirus infections.
In conclusion, ROPV infection of mucosal tissues pro-
vides a small animal model to test host immune re-
sponses to genital papillomavirus infection. The com-
plete ROPV sequence provides information necessary to
generate virus-specific reagents from individual viral
genes to conduct both cell-mediated and serological
assays of immune function in infected hosts.
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460 CHRISTENSEN ET AL.MATERIALS AND METHODS
ROPV genome. The ROPV genome was cloned into a
modified pUC19 plasmid with an inserted Sp1 site as
previously described (Christensen et al., 1996). Sequenc-
ing of both strands was completed with the use of an
automated sequencer (ABI Prism 377XL, DNA se-
quencer, Perkin–Elmer, Foster City, CA) at the core facil-
ities of the Hershey Medical Center. Primers were de-
signed from sequence information to obtain contiguous
sequence data. Sequence analysis was conducted with
the use of the program DNAMAN (Lynnon BioSoft, Que-
bec, Canada).
Infection of genital tissues with ROPV. ROPV infection
of mucosal surfaces of the penis was conducted as
previously described (Harvey et al., 1998). For penile
infections, rabbits were first anesthetized then several
small needle punctures were generated in the mucosal
epithelium of the dorsal surface of the penis using a
25-gauge needle held at a shallow angle. Alternative
strategies included abrasion of an approximately 3-mm2
area of mucosal tissue with fine sandpaper. Infectious
ROPV suspensions (10 ml per site) were placed onto the
wounded sites. Mucosal surfaces of the vaginal opening
of anesthetized female rabbits were either lightly
scoured with the tip of a disposable plastic pipet tip
(without inducing bleeding) or left untreated, followed by
intravaginal application of 10 ml ROPV suspension. Sites
were monitored visually on a weekly basis for detection
of macroscopic lesions. In one experiment, a group of
rabbits received weekly treatments of CsA to induce
specific immune suppression (Shah et al., 1992). Rabbits
eceived twice-weekly subcutaneous injections of CsA
Sandoz Pharma Ltd., Basel, Switzerland) to achieve a
ose of 20 mg/kg body weight for a period of 80 days,
eginning on the day of infection as previously described
Harvey et al., 1998). These rabbits were further subdi-
ided into two groups that were infected at either tongue
r penile sites, respectively.
Production of ROPV L1 VLPs and monoclonal antibod-
es. ROPV L1 VLPs were prepared with the use of recom-
inant baculovirus technology as previously described
Christensen et al., 1994). Primers for the ROPV L1 gene
ere determined from sequence data and used to con-
truct a recombinant baculovirus. Insect High 5 cells
ere infected with this recombinant baculovirus and
LPs were purified from insect cell extracts with the use
f CsCl density gradients. The VLPs were initially tested
n ELISA with serum collected from ROPV-infected rab-
its. ROPV L1 VLPs were injected into mice to develop
onoclonal antibodies (Mabs) reactive to conformational
pitopes on intact ROPV L1 VLP as previously described
Christensen et al., 1990). Five Mabs showing unique
eactivity to the intact ROPV L1 VLP were cloned and
elected for further studies. Purified ROPV L1 VLPs weresed as antigen for testing serological reactivity in serum
ollected from ROPV-infected rabbits.
Serum collection and serological assays. Serum was
repared from rabbits at various time points after ROPV
nfection. ELISAs using intact ROPV L1 VLPs as antigen
ere conducted as described in previous studies (Chris-
ensen et al., 1994). In brief, approximately 1 mg per well
f purified VLPs was attached to ELISA plate wells in
hosphate-buffered saline (PBS; pH 7.0). Denatured VLP
ntigens were attached to plate wells after treatment of
he VLP in carbonate buffer (pH 10.6) containing dithio-
hreitol (Christensen et al., 1994). After 1-h incubation, the
ells were washed and blocked with 5% milk protein in
BS, followed by addition of serum, then alkaline phos-
hatase-labeled swine anti-rabbit antibody (DAKO Corp.,
arpinteria, CA), then substrate. Each dilution of serum
as tested in duplicate ELISA wells, and a mean and
tandard error of the mean values of optical density (OD)
eadings at 410 nm determined. Individual serum anti-
ody titers were calculated as the dilution of serum that
ave 50% of the maximum of the mean OD reading
Christensen et al., 1990).
Competition ELISAs were conducted as previously de-
cribed (Christensen and Kreider, 1993). Fixed dilutions
1:20) of tissue culture supernatant containing Mabs
ere added to wells containing attached intact ROPV L1
LPs. After a 1-h incubation period, the wells were
ashed and 1:50 dilution of rabbit sera from infected
abbits added. The plates were incubated for a further
h then washed, and bound rabbit antibodies detected
ith alkaline phosphatase-labeled swine anti-rabbit sera
nd substrate. Antibody competition was determined as
reduction of mean OD values of wells containing VLPs
ith preincubated Mabs versus control wells without
reincubation with Mabs. A reciprocal competition ex-
eriment was conducted in which ROPV L1 VLP-coated
ells were first incubated with 10-fold dilutions of rabbit
erum followed, after washing, by a 1:20 dilution of su-
ernatant of an ROPV L1 VLP-specific mouse Mab, then
lkaline phosphatase rabbit anti-mouse antisera (DAKO
orp.), then substrate.
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